Oseni Dosage
Generic name: ALOGLIPTIN BENZOATE 12.5mg, PIOGLITAZONE HYDROCHLORIDE 30mg
Dosage form: tablet, film coated
Drug class: Antidiabetic combinations
Medically reviewed by Drugs.com. Last updated on Feb 28, 2025.
2.1 Important Dosage and Administration Information
- Obtain liver tests (serum alanine and aspartate aminotransferases, alkaline phosphatase, and total bilirubin) prior to initiating OSENI.
- Take OSENI orally once daily. Do not split tablets.
- OSENI may be taken with or without food.
- If a dose is missed, do not double the next dose.
2.2 Recommended Dosage and Administration
Recommended Starting Dosage Based on Current Regimen
Individualize the starting dosage of OSENI based on the patient's current regimen and the available strengths of OSENI (see Table 1).
Current Regimen | Starting Dosage of OSENI (alogliptin/pioglitazone) * |
---|---|
|
|
Not treated with either alogliptin or pioglitazone | 25 mg/15 mg or 25 mg/30 mg |
Alogliptin | 25 mg/15 mg or 25 mg/30 mg |
Pioglitazone | 25 mg/15 mg, 25 mg/30 mg, or 25 mg/45 mg |
Alogliptin and pioglitazone | Select a dosage that is as close as possible to the current dosage of alogliptin and pioglitazone |
Dosage Titration for Additional Glycemic Control
Titrate the OSENI dosage gradually, as needed, after assessing therapeutic response and tolerability, up to a maximum dosage of 25 mg of alogliptin and 45 mg of pioglitazone once daily.
2.3 Recommended Dosage for Patients with Renal Impairment
- Assess renal function prior to initiation of OSENI and periodically thereafter.
- The recommended dosage of OSENI in patients with mild renal impairment (creatinine clearance [CrCl] ≥60 mL/min) is the same as the recommended dosage in patients with normal renal function.
- The recommended dosage of OSENI for patients with moderate renal impairment (CrCl ≥30 to <60 mL/min) is 12.5 mg of alogliptin and 30 mg of pioglitazone once daily.
- OSENI is not recommended for patients with severe renal impairment (CrCl ≥15 to <30 mL/min) or ESRD (CrCl <15 mL/min or requiring hemodialysis) because these patients require a lower dosage of alogliptin than what is available in the fixed dose combination product, OSENI.
2.4 Recommendations for Congestive Heart Failure
Starting Dosage in Patients with NYHA Class I or II Congestive Heart Failure
For patients with preexisting NYHA Class I or II congestive heart failure, the recommended starting dosage of OSENI is 25 mg of alogliptin and 15 mg of pioglitazone.
Monitoring for Fluid Retention and Dosage Modifications for Congestive Heart Failure
After initiation of OSENI or with dosage increase, monitor patients carefully for adverse reactions related to fluid retention as has been seen with pioglitazone (e.g., weight gain, edema and signs and symptoms of congestive heart failure).
If congestive heart failure develops while taking OSENI, consider discontinuation of OSENI or dosage reduction of pioglitazone in OSENI.
More about Oseni (alogliptin / pioglitazone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Mounjaro
Mounjaro is used to treat type 2 diabetes in adults. It is a subcutaneous injection that can be ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.